Baolong Ding
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Parents' preference for the inclusion of pediatric vaccines in the Chinese National Immunization Program: A discrete choice experiment.
Journal: Human vaccines & immunotherapeutics
Published: November 21, 2025
Cadonilimab plus chemotherapy for patients with HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma in China and the United States: a cost-effectiveness analysis.
Journal: Therapeutic advances in medical oncology
Published: October 23, 2025
Economics, efficacy and safety of five traditional Chinese medicine injections plus chemotherapy as adjuvant therapy for non-small cell lung cancer: A network meta-analysis.
Journal: International journal of clinical pharmacy
Published: August 26, 2025
Cost‑effectiveness analysis of indocyanine green fluorescence imaging-guided laparoscopic lymphadenectomy for gastric cancer in China.
Journal: Surgical endoscopy
Published: August 22, 2025
Cost-Effectiveness of First-Line Zuberitamab-CHOP versus Rituximab-CHOP Regimens in Untreated CD20+ Diffuse Large B-Cell Lymphoma in China.
Journal: Risk management and healthcare policy
Published: July 14, 2025
Cost-effectiveness analysis of belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma in the United States and China.
Journal: Therapeutic advances in medical oncology
Published: May 15, 2025
Pharmacovigilance analysis of metabolic and nutritional adverse reactions associated with entecavir and tenofovir using the FDA adverse event reporting system database.
Journal: International journal of clinical pharmacy
Published: May 06, 2025
Cost-effectiveness of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a comparative analysis in China, the United States and Europe.
Journal: International journal of clinical pharmacy
Published: September 07, 2024
Perceived Social Support and Health-Related Quality of Life Among Hypertensive Patients: A Latent Profile Analysis and the Role of Delay Discounting and Living Alone.
Journal: Risk management and healthcare policy
Published: July 08, 2024
Impact of national drug price negotiation policy on the accessibility and utilization of PCSK9 inhibitors in China: an interrupted time series analysis.
Journal: International journal for equity in health
Published: April 16, 2024
A survey of availability, price, and affordability of innovative negotiated anticancer medicines: a retrospective study in Jiangsu Province, eastern China.
Journal: BMC public health
Published: December 27, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026